Document Detail


Treatment of advanced bladder cancer by submucosal injection of methotrexate in the anorectal area.
MedLine Citation:
PMID:  1499627     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
In 1988, Shafik et al. presented their first attempt to apply cytostatics in the treatment of pelvic malignancies. Experimentally and clinically, they studied the anal route for administration of methotrexate, and their first results showed that higher concentration of drugs can be achieved in the bladder wall compared to that in serum. Since December 1988, we have been engaged in experimental and clinical investigations of the possibilities this method might reveal. Experiments with animals have proven that submucosal injection of the cytostatic agent does not induce local changes. The clinical trial on 20 patients with tumors of stage T2-T4 has not shown side effects, either local or systemic. The treatment was well tolerated by the patients. Anorexia has been reported in 3, elevated temperature in 2 and leukopenia in 4 of 20 patients. Complete response has been documented in 3 (15%), partial response in 3 (15%), stabilization in 5 (25%) and progression of the disease in 9 (45%) of the patients. Mean duration of remissions was 10.3 months (range 9-12). The distribution of submucously injected contrast medium into the anorectal area has been studied by computerized tomography in 4 of the patients. Although our results do not support the original estimates of the inventors of the method, its ease of application, the possibility of out-patient administration and negligible side effects are sufficient arguments for performing further experimental and clinical studies.
Authors:
C Damyanov; Z Tonchev; N Pavlova; A Ivanov
Related Documents :
637277 - Directional spinals in obstetric analgesia.
10534247 - Safety and efficacy of neurobloc (botulinum toxin type b) in type a-resistant cervical ...
19554227 - The effectiveness of sodium tetradecyl sulfate in the treatment of wrist ganglia.
2059227 - Treatment of de quervain's tenosynovitis with corticosteroids. a prospective study of t...
19381757 - Infective endocarditis in hemodialysis patients: clinical features, echocardiographic d...
6846697 - Mason gastric bypass. long-term follow-up and comparison with other gastric procedures.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  European urology     Volume:  21     ISSN:  0302-2838     ISO Abbreviation:  Eur. Urol.     Publication Date:  1992  
Date Detail:
Created Date:  1992-09-17     Completed Date:  1992-09-17     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7512719     Medline TA:  Eur Urol     Country:  SWITZERLAND    
Other Details:
Languages:  eng     Pagination:  211-5     Citation Subset:  IM    
Affiliation:
Clinic of Urology, Higher Medical Institute, Sofia, Bulgaria.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Rectal
Animals
Carcinoma, Transitional Cell / drug therapy*,  epidemiology,  radiography
Female
Follow-Up Studies
Humans
Male
Methotrexate / administration & dosage*,  therapeutic use
Middle Aged
Rats
Rats, Inbred Strains
Time Factors
Tomography, X-Ray Computed
Urinary Bladder Neoplasms / drug therapy*,  epidemiology,  radiography
Chemical
Reg. No./Substance:
59-05-2/Methotrexate

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Topical chemoprophylaxis of superficial bladder cancer with mitomycin C and adjuvant hyaluronidase.
Next Document:  Frequency of urogenital tuberculosis in an unselected autopsy series from 1928 to 1949 and 1976 to 1...